{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:41:48Z","timestamp":1792611708035,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jcyt.2020.10.006","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T05:57:37Z","timestamp":1608098257000},"page":"211-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Non-invasive monitoring of the kinetic infiltration and therapeutic efficacy of nanoparticle-labeled chimeric antigen receptor T cells in glioblastoma via 7.0-Tesla magnetic resonance imaging"],"prefix":"10.1016","volume":"23","author":[{"given":"Tian","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2020.10.006_bib0001","doi-asserted-by":"crossref","unstructured":"Porter DL, Hwang WT, Frey NV, Lacey SF, Shaw PA, Loren AW, Bagg A, Marcucci KT, Shen A, Gonzalez V, et\u00a0al. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci Transl Med;7(303):303ra139.","DOI":"10.1126\/scitranslmed.aac5415"},{"issue":"11","key":"10.1016\/j.jcyt.2020.10.006_bib0002","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1056\/NEJMoa1504542","article-title":"Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma","volume":"373","author":"Garfall","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcyt.2020.10.006_bib0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrclinonc.2017.128","article-title":"Chimeric antigen receptor T- cell therapies for lymphoma","volume":"15","author":"Brudno","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"399","key":"10.1016\/j.jcyt.2020.10.006_bib0004","doi-asserted-by":"crossref","first-page":"eaaa0984","DOI":"10.1126\/scitranslmed.aaa0984","article-title":"A single dose of peripherally infused EGFRvIII-directed CAR-T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma","volume":"9","author":"O'Rourke","year":"2017","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.jcyt.2020.10.006_bib0005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1001\/jamaoncol.2017.0184","article-title":"HER2-specific chimeric antigen receptor- modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial","volume":"3","author":"Ahmed","year":"2017","journal-title":"JAMA Oncol"},{"issue":"26","key":"10.1016\/j.jcyt.2020.10.006_bib0006","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","article-title":"Regression of glioblastoma after chimeric antigen receptor T-cell therapy","volume":"375","author":"Brown","year":"2016","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.jcyt.2020.10.006_bib0007","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1158\/1078-0432.CCR-14-1421","article-title":"Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases","volume":"21","author":"Katz","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"15","key":"10.1016\/j.jcyt.2020.10.006_bib0008","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1200\/JCO.2014.58.0225","article-title":"Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma","volume":"33","author":"Ahmed","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcyt.2020.10.006_bib0009","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-med-062315-120245","article-title":"CAR T Cell Therapy for Solid Tumors","volume":"68","author":"Newick","year":"2017","journal-title":"Annu Rev Med"},{"issue":"12","key":"10.1016\/j.jcyt.2020.10.006_bib0010","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1158\/1078-0432.CCR-08-0356","article-title":"Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers","volume":"14","author":"Wallace","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jcyt.2020.10.006_bib0011","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1158\/1078-0432.CCR-13-1016","article-title":"Interleukin-7 mediates selective expansion of tumor-redirected cytotoxic T lymphocytes (CTLs) without enhancement of regulatory T-cell inhibition","volume":"20","author":"Perna","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.jcyt.2020.10.006_bib0012","doi-asserted-by":"crossref","DOI":"10.4161\/2162402X.2014.994446","article-title":"IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo","volume":"4","author":"Koneru","year":"2015","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.jcyt.2020.10.006_bib0013","doi-asserted-by":"crossref","first-page":"13754","DOI":"10.1038\/s41598-017-14079-4","article-title":"Canonical NF\u03baB signaling in myeloid cells is required for the glioblastoma growth","volume":"7","author":"Achyut","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2020.10.006_bib0014","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.3389\/fimmu.2018.02788","article-title":"Human CD8+HLA-DR+ Regulatory T Cells, Similarly to Classical CD4+Foxp3+ Cells, Suppress Immune Responses via PD-1\/PD-L1 Axis","volume":"9","author":"Machicote","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.jcyt.2020.10.006_bib0015","doi-asserted-by":"crossref","unstructured":"Chapuis AG, Roberts IM, Thompson JA, Margolin KA, Bhatia S, Lee SM, Sloan L, Lai IP, Farrar EA, Wagener F, et\u00a0al. T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression. J. Clin. Oncol. 2016;34(31):3787-3795.","DOI":"10.1200\/JCO.2015.65.5142"},{"issue":"27","key":"10.1016\/j.jcyt.2020.10.006_bib0016","doi-asserted-by":"crossref","first-page":"23735","DOI":"10.18632\/oncotarget.4362","article-title":"Retargeted human avidin-CAR T cells for adoptive immunotherapy of EGFRvIII expressing gliomas and their evaluation via optical imaging","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"issue":"32","key":"10.1016\/j.jcyt.2020.10.006_bib0017","doi-asserted-by":"crossref","first-page":"14286","DOI":"10.1073\/pnas.1008300107","article-title":"Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses","volume":"107","author":"Koya","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcyt.2020.10.006_bib0018","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1038\/srep04502","article-title":"Tumor lysing genetically engineered T cells loaded with multi-modal imaging agents","volume":"4","author":"Bhatnagar","year":"2014","journal-title":"Sci Rep"},{"issue":"373","key":"10.1016\/j.jcyt.2020.10.006_bib0019","doi-asserted-by":"crossref","first-page":"eaag2196","DOI":"10.1126\/scitranslmed.aag2196","article-title":"Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma","volume":"9","author":"Keu","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcyt.2020.10.006_bib0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-065X.2008.00585.x","article-title":"Non-invasive imaging of adaptive immunity using positron emission tomography","volume":"221","author":"Nair-Gill","year":"2008","journal-title":"Immunol Rev"},{"issue":"11","key":"10.1016\/j.jcyt.2020.10.006_bib0021","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrclinonc.2011.141","article-title":"Noninvasive cell-tracking methods","volume":"8","author":"Kircher","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"issue":"20","key":"10.1016\/j.jcyt.2020.10.006_bib0022","first-page":"6838","article-title":"In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors","volume":"63","author":"Kircher","year":"2003","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.jcyt.2020.10.006_bib0023","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11060-011-0569-6","article-title":"Magnetic resonance imaging targeting of intracranial glioma xenografts by Resovist-labeled endothelial progenitor cells","volume":"105","author":"Wang","year":"2011","journal-title":"J Neurooncol"},{"issue":"7","key":"10.1016\/j.jcyt.2020.10.006_bib0024","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.18632\/oncotarget.1885","article-title":"A new mosaic pattern in glioma vascularization: exogenous endothelial progenitor cells integrating into the vessels containing tumor-derived endothelial cells","volume":"5","author":"Chen","year":"2014","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.jcyt.2020.10.006_bib0025","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/15384047.2015.1016663","article-title":"The expression of P2X7 receptors in EPCs and their potential role in the targeting of EPCs to brain gliomas","volume":"16","author":"Fang","year":"2015","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"10.1016\/j.jcyt.2020.10.006_bib0026","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1258\/ar.2012.120605","article-title":"Effects of magnetically labeled exogenous endothelial progenitor cells on cerebral blood perfusion and microvasculature alterations after traumatic brain injury in rat model","volume":"54","author":"Chen","year":"2013","journal-title":"Acta Radiol"},{"issue":"2","key":"10.1016\/j.jcyt.2020.10.006_bib0027","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrc2289","article-title":"New approaches for imaging tumour responses to treatment","volume":"8","author":"Brindle","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"10.1016\/j.jcyt.2020.10.006_bib0028","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1158\/1078-0432.CCR-13-0895","article-title":"Developing a common language for tumor response to immunotherapy: immune-related response criteria using unidimensional measurements","volume":"19","author":"Nishino","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"24","key":"10.1016\/j.jcyt.2020.10.006_bib0029","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/jnci\/92.24.2029","article-title":"Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors","volume":"92","author":"Chenevert","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.jcyt.2020.10.006_bib0030","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-07-5067","article-title":"Imaging immune response in vivo: cytolytic action of genetically altered T cells directed to glioblastoma multiforme","volume":"14","author":"Lazovic","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jcyt.2020.10.006_bib0031","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2214\/AJR.16.16234","article-title":"Predicting Glioblastoma Recurrence by Early Changes in the Apparent Diffusion Coefficient Value and Signal Intensity on FLAIR Images","volume":"208","author":"Chang","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jcyt.2020.10.006_bib0032","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejrad.2017.06.006","article-title":"Quantitative in vivo imaging of tissue factor expression in glioma using dynamic contrast-enhanced MRI derived parameters","volume":"93","author":"Chen","year":"2017","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.jcyt.2020.10.006_bib0033","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11060-016-2243-5","article-title":"Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF trap in glioblastoma","volume":"130","author":"O'Neill","year":"2016","journal-title":"J Neurooncol"},{"issue":"12","key":"10.1016\/j.jcyt.2020.10.006_bib0034","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00234-015-1582-9","article-title":"Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas","volume":"57","author":"Piludu","year":"2015","journal-title":"Neuroradiology"},{"issue":"4","key":"10.1016\/j.jcyt.2020.10.006_bib0035","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jmri.25835","article-title":"Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading","volume":"47","author":"Xie","year":"2018","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"10.1016\/j.jcyt.2020.10.006_bib0036","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/WCO.0b013e32834cd523","article-title":"Investigating white matter injury after mild traumatic brain injury","volume":"24","author":"Sharp","year":"2011","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"10.1016\/j.jcyt.2020.10.006_bib0037","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000455837","article-title":"Susceptibility-Weighted Imaging Identifies Iron-Oxide-Labeled Human Neural Stem Cells: Automated Computational Detection","volume":"38","author":"Baghchechi","year":"2016","journal-title":"Dev Neurosci"},{"issue":"12","key":"10.1016\/j.jcyt.2020.10.006_bib0038","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2217\/imt-2016-0125","article-title":"Prospects to improve chimeric antigen receptor T-cell therapy for solid tumors","volume":"8","author":"Jin","year":"2016","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1016\/j.jcyt.2020.10.006_bib0039","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/PPO.0000000000000032","article-title":"CAR T cells for solid tumors: armed and ready to go?","volume":"20","author":"Kakarla","year":"2014","journal-title":"Cancer J."},{"issue":"5","key":"10.1016\/j.jcyt.2020.10.006_bib0040","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nm.3833","article-title":"Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes","volume":"21","author":"Caruana","year":"2015","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jcyt.2020.10.006_bib0041","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/mrm.1910230203","article-title":"The TH, de Leij L. Dextran-magnetite particles: contrast-enhanced MRI of blood-brain barrier disruption in a rat model","volume":"23","author":"Bulte","year":"1992","journal-title":"Magn Reson Med"},{"issue":"5","key":"10.1016\/j.jcyt.2020.10.006_bib0042","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/mrm.1910300513","article-title":"Intracellular Labeling of T-Cells with Superparamagnetic Contrast Agents","volume":"30","author":"Yeh","year":"1993","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jcyt.2020.10.006_bib0043","doi-asserted-by":"crossref","first-page":"14055","DOI":"10.1038\/srep14055","article-title":"Magnetic particle imaging tracks the long-term fate of in vivo neural cell implants with high image contrast","volume":"5","author":"Zheng","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jcyt.2020.10.006_bib0044","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/cmmi.1658","article-title":"Superparamagnetic iron oxide nanoparticles for direct labeling of stem cells and in vivo MRI tracking","volume":"11","author":"Kim","year":"2016","journal-title":"Contrast Media Mol Imaging"},{"issue":"5","key":"10.1016\/j.jcyt.2020.10.006_bib0045","doi-asserted-by":"crossref","first-page":"e19662","DOI":"10.1371\/journal.pone.0019662","article-title":"Monitoring of in vivo function of superparamagnetic iron oxide labelled murine dendritic cells during anti-tumour vaccination","volume":"6","author":"Tavar\u00e9","year":"2011","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1016\/j.jcyt.2020.10.006_bib0046","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2009.07.010","article-title":"Diffusion-weighted imaging and apparent diffusion coefficient evaluation of herpes simplex encephalitis and Japanese encephalitis","volume":"287","author":"Sawlani","year":"2009","journal-title":"J Neurol Sci"},{"issue":"10","key":"10.1016\/j.jcyt.2020.10.006_bib0047","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00234-010-0802-6","article-title":"MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot study","volume":"53","author":"Vrabec","year":"2011","journal-title":"Neuroradiology"},{"issue":"2","key":"10.1016\/j.jcyt.2020.10.006_bib0048","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00234-016-1769-8","article-title":"Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma","volume":"59","author":"Qin","year":"2017","journal-title":"Neuroradiology"},{"issue":"9","key":"10.1016\/j.jcyt.2020.10.006_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108414","article-title":"Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma","volume":"9","author":"Rygh","year":"2014","journal-title":"PLoS One"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324920309312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324920309312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:42:21Z","timestamp":1761442941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324920309312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1465324920309312"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2020.10.006","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-invasive monitoring of the kinetic infiltration and therapeutic efficacy of nanoparticle-labeled chimeric antigen receptor T cells in glioblastoma via 7.0-Tesla magnetic resonance imaging","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2020.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}